Patents
Literature
1 results about "Percutaneous coronary intervention" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Percutaneous coronary intervention (PCI) is a non-surgical procedure used to treat narrowing (stenosis) of the coronary arteries of the heart found in coronary artery disease. After accessing the blood stream through the femoral or radial artery, the procedure uses coronary catheterization to visualise the blood vessels on X-ray imaging. After this, an interventional cardiologist can perform a coronary angioplasty, using a balloon catheter in which a deflated balloon is advanced into the obstructed artery and inflated to relieve the narrowing; certain devices such as stents can be deployed to keep the blood vessel open. Various other procedures can also be performed.
Use of biomarker in the preparation of kit used in method for early warning of prognosis risk in patient with acute st-segment elevation myocardial infarction
Disclosed is a method for early warning of a prognosis risk in a patient with acute ST-segment elevation myocardial infarction. The biomarker comprises HBP. The present application can effectively evaluate whether patients with acute ST-segment elevation myocardial infarction will experience poor prognosis within 30 days after PCI by monitoring changes in HBP levels, thereby achieving early identification and timely clinical intervention for high-risk patients, improving the response speed and effect of treatment, reducing the incidence of adverse cardiovascular events, and ultimately improving prognosis of patients.
Owner:JOINSTAR BIOMEDICAL TECH CO LTD